Mexico Heparin Market Size & Outlook, 2023-2030
Mexico heparin market, 2018-2030 (US$M)
Related Markets
Mexico heparin market highlights
- The Mexico heparin market generated a revenue of USD 70.0 million in 2023 and is expected to reach USD 92.4 million by 2030.
- The Mexico market is expected to grow at a CAGR of 4% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
Heparin market data book summary
| Market revenue in 2023 | USD 70.0 million |
| Market revenue in 2030 | USD 92.4 million |
| Growth rate | 4% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.9% of the global heparin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil heparin market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 92.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 89.14% in 2023. Horizon Databook has segmented the Mexico heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico’s National Blood Transfusion Center is a part of the National Institutes of Health. CNTS is a government agency that establishes policies and regulations on transfusion medicine. Low awareness about blood donation and high risk of transfusion-transmitted infections are creating a demand for good clinical practices to be implemented in this region, with more support from the government.
The country’s market is driven by its increase in prevalence of chronic diseases, improvements in healthcare infrastructure, growing consumer awareness. According to statistics published by the Institute for Health Metrics and Evaluation, ischemic heart disease was the leading cause of death in 2017, accounting for an increase in 60.4% from 2007 to 2017.
Stroke is a major financial burden on Mexico’s healthcare industry, with a prevalence of 84.2 per 100,000 population. Although the geriatric population is currently moderate in the region, it is expected to grow at a rapid pace over the upcoming years, which is expected to elevate the prevalence of stroke and DVT. These factors are expected to propel the market over the forecast period.
Reasons to subscribe to Mexico heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico heparin market , including forecasts for subscribers. This country databook contains high-level insights into Mexico heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico heparin market size, by source, 2018-2030 (US$M)
Mexico Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
